SVP, GC & Corporate Secretary of Travere Therapeutics, Inc. (U.S.: Nasdaq:TVTX), Reed Elizabeth E, sells 5,000 shares worth $137,000
According to Travere Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 12 04:07 PM, company SVP, GC & Corporate Secretary, Reed Elizabeth E disclosed selling 5,000 shares at a cost of $27.40. At the time of this transaction (Jan 11), this trade was worth $137,000 in total. As of Jan 11, Reed Elizabeth E now owns 37,548 shares in total worth about $982,631.16.
For the last few recent trades made by Travere Therapeutics, Inc. (U.S.: Nasdaq:TVTX) SVP, GC & Corporate Secretary, Reed Elizabeth E, we have the following information:
- SEC Form 4 filing: Aug 17: Sold 1,407 shares at the rate of $17.12 per share. Total worth of this trade was $24,086. Total number of shares owned as of Aug 17 were 37,548
- SEC Form 4 filing: May 11: Sold 1,625 shares at the rate of $19.14 per share. Total worth of this trade was $31,102. Total number of shares owned as of May 11 were 36,080
- SEC Form 4 filing: May 12: Sold 1,625 shares at the rate of $19.46 per share. Total worth of this trade was $31,622. Total number of shares owned as of May 12 were 34,455
Posted by
George Daniels
on Thursday January 13 2022, 1:34 PM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
